Evaluation of the safety and tolerability of a high-dose intravenous infusion of allogeneic mesenchymal precursor cells

Intravenous delivery of a single high-dose infusion of oMPCs is well tolerated in a large animal model. This study provides additional safety evidence for their intravenous use in future human clinical trials.